Stock Report

Neuland Laboratories Ltd consolidated Q4 FY26 PAT surges to Rs. 212.67 crores

Posted On : 2026-05-12 21:29:01( TIMEZONE : IST )

Neuland Laboratories Limited has reported Consolidated financial results for the period ended March 31, 2026.

Financial Results (Q4 FY2026) - QoQ Comparison

The company has reported total income of Rs. 788.7085 crores during the period ended March 31, 2026 as compared to Rs. 447.7617 crores during the period ended December 31, 2025.

The company has posted net profit / (loss) of Rs. 212.6726 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 40.5719 crores for the period ended December 31, 2025.

The company has reported EPS of Rs. 165.76 for the period ended March 31, 2026 as compared to Rs. 31.62 for the period ended December 31, 2025.

Financials	Q4 FY2026	Q3 FY2026	% Change
Total Income	₹ 788.7085 crs	₹447.7617 crs	76.14%
Net Profit	₹212.6726 crs	₹40.5719 crs	424.19%
EPS	₹165.76	₹31.62	424.23%

Financial Results (Q4 FY2026) - YoY Comparison

The company has reported total income of Rs. 788.7085 crores during the period ended March 31, 2026 as compared to Rs.335.8243 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs.212.6726 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.27.8059 crores for the period ended March 31, 2025.

The company has reported EPS of Rs.165.76 for the period ended March 31, 2026 as compared to Rs.21.67 for the period ended March 31, 2025.

Financials	Q4 FY2026	Q4 FY2025	% Change
Total Income	₹ 788.7085 crs	₹335.8243 crs	134.86%
Net Profit	₹212.6726 crs	₹27.8059 crs	664.85%
EPS	₹165.76	₹21.67	664.93%

Financial Results (Year Ended FY2026) - YoY Comparison

The company has reported total income of Rs.2053.1516 crores during the Financial Year ended March 31, 2026 as compared to Rs.1497.3466 crores during the Financial Year ended March 31, 2025.

The company has posted net profit / (loss) of Rs.363.9984 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.260.1081 crores for the Financial Year ended March 31, 2025.

The company has reported EPS of Rs.283.71 for the Financial Year ended March 31, 2026 as compared to Rs.202.74 for the Financial Year ended March 31, 2025.

Financials	Year Ended FY2026	Year Ended FY2025	% Change
Total Income	₹2053.1516 crs	₹1497.3466 crs	37.12%
Net Profit	₹363.9984 crs	₹260.1081 crs	39.94%
EPS	₹283.71	₹202.74	39.94%

Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 17000.55 as compared to the previous close of Rs. 17548.30. The total number of shares traded during the day was 4177 in over 1648 trades.

The stock hit an intraday high of Rs. 17730.00 and intraday low of 16912.25. The net turnover during the day was Rs. 71975769.00.